Skip to main content

Sandra Mancilla Zamora

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Sandra Mancilla Zamora

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Degrees:
Stable animal experimentation course. ABC function in 2020
Senior Clinical Analysis Technician in 2005
Higher Techniques in Pathological Anatomy and Cytology in 2001.

Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017
Technician in charge of the histology section of FVPR and the DDT group of the VHIR.
With knowledge in environment and quality management at ISO 9001. Application management, internal positions…
They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune.
I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing.
Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.

Projects

Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH

IP: María José Buzón Gómez
Collaborators: Juan Lorente Guerrero, Laura García Latorre, Jordi Temprana Salvador, Joaquin Seras Franzoso, Simon Schwartz Navarro, Jordi Navarro Mercadé, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Judit Grau Exposito, Meritxell Genesca Ferrer, Diana Fernandes de Rafael
Funding agency: Fundació La Marató de TV3
Funding: 199998.75
Reference: 20180510
Duration: 10/05/2019 - 31/12/2022

Evolvable platform for designing cancer treatment strategies using nanoparticles (EVO-NANO)

IP: -
Collaborators: Joaquin Seras Franzoso, Simon Schwartz Navarro, Sandra Mancilla Zamora, Evolvable platform for designing cancer treatment strategies using nanoparticles (EVO-NANO), Belen Garcia Prats
Funding agency: EUROPEAN COMMISSION
Funding: 568847.5
Reference: EVO-NANO_H2020FETOPEN2017
Duration: 01/10/2018 - 31/03/2022

Mejora del tratamiento de las enfermedades de depósito lisosomal mediante vehículos nanométricos optimizados.

IP: -
Collaborators: Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Diana Fernandes de Rafael
Funding agency: Instituto de Salud Carlos III
Funding: 116160
Reference: PI18/00871
Duration: 01/01/2019 - 30/06/2022

SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH..

IP: Simon Schwartz Navarro
Collaborators: Julia German Cortes, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Maria Fidel Lledò, Olga Sánchez- Maroto Carrizo, Belen Garcia Prats, Diana Fernandes de Rafael
Funding agency: EUROPEAN COMMISSION
Funding: 649580
Reference: SAFE-N-MEDTECH_S.SCHWARTZ_H2020_2018
Duration: 01/04/2019 - 30/09/2023

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

Related professionals

Sandra León Cobos

Sandra León Cobos

Gestió i Administració
Learning and Development Unit
Human Resources Directorate
Read more
Sandra Trujillo Martín

Sandra Trujillo Martín

Gestió i Administració
Labour Relations Unit
Human Resources Directorate
Read more
Imma Garcia Ruiz

Imma Garcia Ruiz

Research assistant
Donation and transplantation of organs, tissues and cells
Read more
Miquel Polo Sabater

Miquel Polo Sabater

Predoctoral researcher
Infection and immunity in pediatric patients
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.